Staying ahead of antimalarial drug resistance

Artemisinin-based combination therapies (ACTs) are foundational to treating malaria, saving millions of lives over the last twenty years. However, emerging drug resistance patterns, along with gaps in treatment coverage and incomplete adherence to multidose regimens, raise important questions about how to best protect the efficacy of these essential medicines. As resistance trends evolve, how can countries, researchers, and partners work together to ensure ACTs remain effective for as long as possible? This session will explore how antimalarial resistance and real-world use shape treatment policy decisions and guide drug development to protect decades of progress and keep communities safe.

This webinar will cover:

• The current landscape of antimalarial drug resistance (AMDR) and the strategies countries are using to protect ACT effectiveness
• The role of diagnostics, surveillance, treatment coverage, and patient compliance in supporting responsible use of malaria medicines
• How AMDR trends inform decisions about new drug development and guide treatment policies to safeguard existing therapies